XML 20 R10.htm IDEA: XBRL DOCUMENT

Investments, Equity Method and Joint Ventures	3 Months Ended
Investments, Equity Method and Joint Ventures	Mar. 29, 2026
Equity Method Investments and Joint Ventures [Abstract]
EQUITY INVESTMENT	EQUITY INVESTMENT As of March 29, 2026, the Company held 10,803,620 shares of Series C Preferred Stock of Wonder, received as partial consideration in connection with the Spyce sale (see Note 8). The Company holds a minority interest and does not have significant influence over Wonder. Wonder is a privately held company, and as such, the preferred shares comprising the Company’s investment are illiquid and fair value is not readily determinable. The Company accounts for this investment at cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. For the thirteen weeks ended March 29, 2026, no adjustments have been recognized related to the investment. The investment is included within equity investments on the condensed consolidated balance sheets with a carrying value of $86.4 million as of March 29, 2026.